Afghanistan's narcotics problems grow worse

By R. Jeffrey Smith and Mattie Quinn

A costly and ambitious U.S. effort to curtail Afghanistan's poppy production falters as U.S. forces draw down.

OPINION: drug firms say no to rebates, despite billions in new revenue from Part D

By Wendell Potter

Part D brought drug companies billions, but they say the sky is falling

Drug lobby donation went to pro-Democratic nonprofit

By Michael Beckel

Half-million-dollar donation from PhRMA went to little-known group that backed Harry Reid.

Excerpts from this story referencing "UPS":

"… ipient of the drug lobby’s donation, lists its address as a mailbox in a UPS store in Washington, D.C.The Center was able to track down the recipient o …"

Panel recommends new agency to investigate safety of health information technology

By Kimberly Leonard

Institute of Medicine panel recommends new regulatory body, not FDA

Excerpts from this story referencing "Food":

"… endent research and advisory organization, is explicitly advising that the Food and Drug Administration (FDA) not be tasked with the job at this time — …"

Overmedicating young Louisiana inmates

By Matt Davis

Incarcerated youths in Louisiana are receiving powerful drugs even when their conditions don't call for it

Investigations Around the World

By Simona Raetz

Drug on wars makes pain killers unavailable for patients in developing countries; mining companies are big winners of Chilean tax system

Feds have done little to contain genetically modified animals and plants

By Laurel Adams

Government has done little to ensure genetically modified animals and plants don't escape into wild

Excerpts from this story referencing "FDA":

"… claimed that these pigs did not inherit the inserted genetic material, but FDA could not confirm this. The FDA investigator said that under the terms of …"

"… inherit the inserted genetic material, but FDA could not confirm this. The FDA investigator said that under the terms of the study protocols, the animals …"

"… s authority over GE animals and insects that are considered pests, but the FDA has responsibility over GE animal approvals of new animal drugs that could …"

"… s for GE plants. While jurisdiction over GE animals and insects belongs to FDA, APHIS has authority over the importation, interstate movement, and field …"

$1 billion for anti-narco programs, and no central database to track it

By Laurel Adams

State Department doesn't have a central tracking mechanism for its $1 billion counter-narcotics programs

FDA screening of fish imports not catching antibiotics and drug residue

By Laurel Adams

FDA taken to task for sloppy inspections of imported fish

Excerpts from this story referencing "China":

"… iginate in developing countries. The top seafood exporters to the U.S. are China, Thailand, Canada, Indonesia, Vietnam and Ecuador. …"

Medicare can’t identify top prescribers of addictive drugs

By The Center for Public Integrity and Joe Eaton

Medicare doesn't know if all the prescriptions it is paying for are being written by real doctors, says a new inspector general's report....

Medicare patients received expired, terminated drugs

By Joe Eaton

Medicare patients in 2006-07 likely received more than $112 million worth of expired prescription drugs or drugs that have been pulled from

In health, like everything else, men and women really are different

By Amy Biegelsen

Health studies still do not adequately root out differences between men and women, according to a new report from the National Academy of Sc

Excerpts from this story referencing "diseases":

"… a shift toward more accurate research and regulation.Clinical trials about diseases, devices and drugs don’t regularly analyze outcomes by sex or gender “ …"

"… sis,” the report says.One factor keeping women out of trials can be that diseases present themselves differently. So a cardiovascular-disease trial with inc …"

"… ough men have shorter life expectancy and an earlier average onset of many diseases.Other new watchdog reports released by the Government Accountability Offic …"

Senator seeks deadline for Medicare to prevent prescription drug fraud

By Joe Eaton

Taxpayer-funded Medicare recently spent more than $1 billion on drug prescriptions missing a valid doctor identification number and a Senate

Most drug trial results analyzed by FDA hidden from view

By Naseem Miller

Before a new drug finds its place on pharmacy shelves or a new device lands in the hands of a surgeon, it goes through a long and complex ap

Excerpts from this story referencing "FDA":

"… testing and animal studies before the drugmaker submits an application to FDA’s Center for Drug Evaluation and Research. If it gets the agency’s gre …"

"… out how the drug works and its possible side effects are then submitted to FDA for final approval.But can consumers search online to find the clinical tr …"

"… Health. And information about trial data on drugs and devices that failed FDA’s approval process is unlikely to be available anywhere.Clinicians and a …"

"… works, and what doesn’t,” said Goozner, who has been writing about the FDA and the drug industry for more than a decade. All clinical trials are curr …"

FDA asks hospitals to report safety glitches in digital health systems

By Fred Schulte and Emma Schwartz

In letter to 350 health centers, agency signals growing concern

FDA considers regulating safety of electronic health systems

By Fred Schulte and Emma Schwartz

Reports of patient harm include six deaths in two years

Excerpts from this story referencing "federal government":

"… said. “This transparency is especially important at a time when the federal government—and the American public—are investing heavily in HIT,” wrote Gay M. …"

"… e and adverse events associated with the use of such products.” The federal government’s Office of the National Coordinator for health information technology a …"

FDA lags USDA in accessible food safety data

By Jim Morris

Recent outbreaks of food-borne illness left American consumers on edge — and largely in the dark about federal enforcement. The Food and Dru

Major gaps in oversight of human medical research

By Jeanne Lenzer and Shannon Brownlee

Columbia Hospital case a cautionary tale

Government orders Columbia to tell patients 'true nature' of drug study

By Jeanne Lenzer and Shannon Brownlee

Officials say research may have caused harm to people who had heart surgery

Excerpts from this story referencing "pain":

"… nts, my primary focus in the operating room is patient safety and reducing pain and suffering.”An Unrestricted GrantThe Columbia study came at a time wh …"

ATF’s ‘ad hoc’ efforts give tobacco smugglers a free pass

By Te-Ping Chen

Smuggling cigarettes in America has become a multi-billion-dollar business, robbing states of desperately needed tax money and fueling organ

Excerpts from this story referencing "Smuggling":

"… have a good sense of the level of tobacco diversion across the country.” …"

Painkiller trial raises questions for FDA, Pfizer

By Shannon Brownlee and Jeanne Lenzer

In February 2005, the U.S. Food and Drug Administration (FDA) called a three-day hearing to review the risks of three painkillers known as C

Excerpts from this story referencing "Gaithersburg":

"… 2-member panel of outside advisers assembled in a Hilton Hotel ballroom in Gaithersburg, Maryland, to hear testimony from scientists, patients, and drug company r …"

FDA reaches agreement with firm that produced troubled heart drug

The U.S. Food and Drug Administration last week announced a little-noticed tentative agreement setting conditions under which a troubled pha

Excerpts from this story referencing "FDA":

"… nter found that 667 deaths were reported between April 1 and June 30 to an FDA database by doctors, other health professionals, and consumers who cited D …"

"… ” efforts. Then in November, the Justice Department — representing the FDA — asked a federal judge to permanently enjoin Actavis and Actavis Totowa …"

"… turing a variety of drugs until the firm could demonstrate compliance with FDA “Good Manufacturing Practice” requirements.The FDA’s announcement st …"

"… ate compliance with FDA “Good Manufacturing Practice” requirements.The FDA’s announcement states that it filed a proposed consent decree with a fed …"

Did the FDA miss signals on a troubled heart drug?

By Jeanne Lenzer

It has been a rough eight months for the drug maker Actavis, Inc. and its powerful heart drug, Digitek. Following repeated Food and Drug Adm

Excerpts from this story referencing "manufacturing plant":

"… n of the dangers of selling the drug because of well-known problems at the manufacturing plant and that it did so to “maximize sales and profits at the expense of the …"

Lack of adequate foreign drug oversight

By The Center for Public Integrity

The GAO called for improvement in the FDA’s Foreign Drug Inspection Program in 1998. A decade later, there's been little improvement.

Excerpts from this story referencing "pharmaceuticals":

"… rs, distributors, repackagers, and other players involved in the import of pharmaceuticals,” in the wake of the globalization of the pharmaceutical supply chain. T …"

Problems in oversight of food safety

By The Center for Public Integrity

Food safety oversight agencies often inconsistent and ineffective, says GAO

FDA failure to ensure drug safety

By The Center for Public Integrity

Vioxx dangers raise questions about FDA's ability to monitor drugs

The expert: watch an interview with Luk Joossens

By ICIJ

Watch an interview with Luk Joossens

More big money from pharmaceutical lobby in 2008

By Mary Beth Lombardo

The economy may be sliding, but that hasn’t stemmed the high-rolling habits of Washington’s largest lobby. In 2007, as the Center recently r

A record year for the pharmaceutical lobby in '07

By M. Asif Ismail

Washington's largest lobby racks up another banner year on Capitol Hill

Spending on lobbying thrives

By M. Asif Ismail

Drug and health products industries invest $182 million to influence legislation

Excerpts from this story referencing "pharmaceuticals":

"… his report was provided by the Nathan Cummings Foundation. …"

"… PhRMA lobbyist.The Center's latest study showed that the manufacturers of pharmaceuticals, medical devices and other health products have spent at least $855 millio …"

Pages